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Flexibility and Adaptation: 
Key Elements for Preserving Research Continuity During the COVID-19 Pandemic 
Mindy George-Weinstein, Ph.D. 
Chief Research and Science Officer, Division of Research, Philadelphia College of Osteopathic 
Medicine 
Limiting the spread of the coronavirus by social-distancing has eclipsed nearly all normal daily 
activities and routines. Healthcare services for those with COVID-19 and protection of 
vulnerable populations have escalated exponentially. State and local governments are mandating 
closure of non-essential businesses while classifying operations of pharmaceutical and 
biotechnology companies as essential. Education of students at all levels is, for the most part, 
virtual across the U.S. 
Epidemiologic studies, development of a vaccine and other prevention and treatment strategies, 
examination of correlates of disease resistance and analyses of the coronavirus itself are critical 
for combating the COVID-19 pandemic. Research in these areas is being conducted at an 
aggressive pace in federal and private sector institutions.1 The questions become, what research 
activities unrelated to the corona virus and COVID-19 are essential and at what level should 
ongoing programs be maintained when safety is the first priority? 
Restrictions aimed at preventing disease spread have been imposed in all research facilities. 
Clinical trial centers and universities have developed and shared recommendations for research 
in the face of COVID-19 with guidance from the Center for Disease Control and Prevention 
(CDC) and the National Institutes of Health (NIH).2,3 Continuation of clinical trials is essential 
for monitoring subject safety and assessing outcomes. The NIH recommends flexibility in the 
timing and location of testing, limiting study visits to those needed for the safety of participants 
and clinical care, and conducting virtual study visits.4 Institutional Review Boards are 
encouraged to be responsive to the need for out-of-cycle reviews of amendments to study 
protocols. 
Continuity of basic and translational research programs must be given thoughtful and 
individualized consideration. Policies vary in their level of restriction of activities and access to 
laboratories and core facilities, ranging from a complete shutdown of projects and buildings to 
limited occupancy for essential operations. Definitions of essential operations also vary, but 
generally include tasks and services required to maintain continuity of research programs that in 
many cases have developed over the course of years and even decades. A minimal level of 
activity includes safe storage of tissue samples, cell lines, biologics and other reagents, and daily 
husbandry of preclinical research models. Time sensitive analyses may be considered essential 
for completing ongoing experiments. In some institutions, principal investigators (PIs) and 
research support staff have been assigned essential tasks on a rotating basis in order to reduce 
population density to a bare minimum. Work-study students are considered employees, and 
although they are important contributors to our research programs, they are likely to have 
restricted access to facilities, in some cases with continued financial support. 
All research personnel are encouraged or required to work remotely to the extent possible. 
Literature searches, data reduction and interpretation, and preparation of manuscripts, grant 
applications and progress reports can be performed off-site with access to the internet, library 
holdings, institutional servers and software site licenses. Working remotely with fewer 
distractions than normally experienced in a research intensive or academic environment can be 
productive. However, many faculty are currently consumed with creating and providing 
educational content online for at least one semester. Postdoctoral fellows, graduate students and 
experienced research support staff can shoulder a great deal of the responsibility for data 
management and preparing drafts of papers while PIs respond to the shift in their teaching 
methods. 
The scale-back of experimentation poses additional challenges for the continuation of research 
focused degree programs. A cohort of graduate students anticipates completion of their degree by 
late spring and have already been accepted into PhD programs, postdoctoral fellowships and 
medical and dental schools. Advisors and thesis committee members are strongly encouraged to 
reevaluate preexisting milestones and be flexible in their requirements for data accumulation. 
Remote access to PubMed and statistical, graphing and image analysis programs will facilitate 
completion of the written thesis. The oral defense can occur via videoconferencing. 
Additional recommendations for students and other trainees engaged in research pertain to the 
curriculum vitae (CV). This is an active time for applying to advanced degree programs, 
postdoctoral fellowships, graduate medical education residencies and employment. 
Documentation of research accomplishments within the CV enhances applicants’ 
competitiveness for these positions. Publications are an important measure of research 
productivity. Submission of manuscripts will likely be delayed as a result of reduced access to 
research facilities. While reviewers of manuscripts always should be judicial in their 
expectations for additional experimentation, this is especially important now when it is unclear 
when research operations will return to normal and what resources will be available to support 
reactivation of projects. 
Presentations to the scientific community are another important metric of scholarship. Trainees 
and faculty have experienced tremendous disappointment resulting from cancellation of regional, 
national and international conferences. Titles of abstracts, accompanied by a statement that they 
were invited to give a platform or poster presentation at the conference, followed by a notation 
that the conference was cancelled, can be included in the CV. Some conferences are allowing 
online presentations. This option must be carefully considered given the potential for unwanted 
methodology and data capture. 
The scientific community has been part of an extraordinary effort to communicate, cooperate and 
adapt to significant reductions in or temporary cessations of their research programs imposed by 
the spread of the coronavirus. Highly focused and productive researchers are now more flexible 
in their expectations for the pace of experimentation and progress of their mentees. Clearly, 
research programs will suffer setbacks from interruptions in work flow and lost resources. Loss 
may be minimized by inclusion of active researchers in the process of developing and updating 
policies to maintain the highest possible level of safety. Purpose, vigor, ingenuity and financial 
support will drive a dramatic resurgence in research that will accompany the control of the 
COVID-19 pandemic. 
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